Studies on drug-assisted silver nanoparticles to reduce granulocytopenia and improve drug delivery for cancer therapy

2021 ◽  
Vol 127 (5) ◽  
Author(s):  
Chetan Chavan ◽  
Saniya Prabhune ◽  
Siddhi Shedge ◽  
Rajashree Patwardhan ◽  
Sagar Kamble ◽  
...  
Nano Letters ◽  
2013 ◽  
Vol 13 (6) ◽  
pp. 2528-2534 ◽  
Author(s):  
Tuo Wei ◽  
Juan Liu ◽  
Huili Ma ◽  
Qiang Cheng ◽  
Yuanyu Huang ◽  
...  

2020 ◽  
Vol 25 (9) ◽  
pp. 1727-1734
Author(s):  
Xiaocong He ◽  
Yuanyuan Yang ◽  
Lingxiao Li ◽  
Penghui Zhang ◽  
Hui Guo ◽  
...  

2021 ◽  
Vol 407 ◽  
pp. 127202 ◽  
Author(s):  
Anam Rana Gul ◽  
Farhat Shaheen ◽  
Rafia Rafique ◽  
Jyotiranjan Bal ◽  
Shahid Waseem ◽  
...  

2021 ◽  
Vol 7 (2) ◽  
pp. 01-17
Author(s):  
Ritika Sahajwani ◽  
Manish Srivastava ◽  
Anamika Srivastava ◽  
Chanchal Parashar ◽  
Agrima Singh ◽  
...  

The overview of this review article depends on the various techniques of formation of silver nanoparticles and different application take place in medicinal point of view. The branch of nanotechnology plays an important role in medical science research. In this different nanoparticle is synthesized which have various application in gene delivery, drug delivery and reduce the toxic effect of drugs in the human body and also act as an antibacterial in pharmaceutical industries. In recent days silver nanoparticles have had an important role due to their optical and catalytic properties. A large number of different particles or methods are used to prepare the different shapes of silver nanoparticles used in drug delivery. Different shapes of nanoparticles have increased their demand in various researches depend on medicinal uses. Silver nanoparticle preparation can be studied by 3 techniques related to irradiations, chemicals, bacteria, fungi, and plants.  Nanomedicine have a large number of advantages in treating various chronic diseases by using biological agents, chemotherapeutic agents, and used to deliver the drug to a specific site of the body. A silver nanoparticle is prepared for detection tool to detect the adverse effect of diseases on the target cell. Nanoparticles are used in cancer therapy to remove the damaged cell of the body. 


2009 ◽  
Vol 6 (7) ◽  
pp. 727-744 ◽  
Author(s):  
M Wirth ◽  
VE Plattner ◽  
F Gabor

2018 ◽  
Vol 5 (3) ◽  
pp. 175-187 ◽  
Author(s):  
O. V. Gorovtsova ◽  
T. L. Ushakova ◽  
V. G. Polyakov

Retinoblastoma is one of highly curable diseases; today the total 5-year survival rate in patients with retinoblastoma exceeds 95%. The article summarizes the current world experience on treatment of patients with intraocular retinoblastoma. The treating skills of intraocular malignant tumor in children are a balance between the patient’s life and the preservation of an eye and its visual functions. The complex and challenging task is the treatment of common intraocular retinoblastoma groups «C», «D», «E» when the large size or localization of the tumor does not allow performing the local (focal) destruction of the tumor. As a rule, in such cases neoadjuvant chemotherapy (CT) is performed at the first stage in order to reduce the size of the tumor for further focal therapy. However, the analysed data on the effectiveness of neoadjuvant CT in combination with focal or radiotherapy demonstrated the limited possibilities of the proposed therapy. Local drug delivery in cancer therapy became a real breakthrough in the organ-preserving treatment of children with large intraocular retinoblastoma. The most widely used current methods of local drug delivery are intravitreal (IVitC) and selective intra-arterial chemotherapy (SIAC) as monotherapy or in combination with neoadjuvant CT and focal therapy which significantly increased the percentage of preserved eyes without radiotherapy administration or damage to the patient survival. The review discusses the different IVitC and SIAC techniques, chemotherapy schemes, dosages of chemotherapy, immediate and long-term complications of treatment.


Author(s):  
Azadi A. ◽  
Khazaei M. ◽  
Ashrafi H.

Cancer, an uncontrollable growth of cells, is among the leading causes of mortality and morbidity throughout the world. Malignant neoplasms are difficult to treat diseases because of their single in kind characteristics such as tissue invasion, metastasis, evading reticuloendothelial system (RES) and so forth. In recent decade polymeric nanoparticulate systems has gained special attention in drug delivery and targeting among all biocompatible nanoforms. Among these systems, chitosan-based hydrogel nanoparticles have been wildly utilized for drug delivery purposes. The usage of chitosan nanogels in cancer therapy significantly improved in recent years. The various cancers were the target of chitosan nanogels. Also, modification of other delivery systems with chitosan were much reported. The aim of this study is the review and update of the recent studies on chitosan nanogels applications in cancer therapy by focus on cancer based classification.


2013 ◽  
Vol 40 (10) ◽  
pp. 1039
Author(s):  
Yang YANG ◽  
Wen-Chuan SHE ◽  
Kui LUO ◽  
Zhong-Wei GU

Sign in / Sign up

Export Citation Format

Share Document